1. "Bone Marrow Transplant"
Formats
  1. Meeting Abstract (1488)
  2. Journal Article (1179)
  3. Review (70)
  4. Research Letter (46)
  5. Book Section (34)
  6. Guidelines (26)
  7. Editorial (23)
  8. Correspondence (17)
  9. Conference Paper (14)
  10. Book Whole (1)
  11. Miscellaneous (1)
Groups
  1. Bone Marrow Transplant (2899)
  2. Center for Hematologic Malignancies (2899)
  3. Department of Medicine (2899)
  4. Hematologic Malignancies, Division of (2776)
  5. Survivorship Research (1345)
  6. GSK Faculty (917)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Sean Devlin (457)
  4. Ann Jakubowski (456)
  5. Heather Landau (419)
  6. Gunjan Shah (418)

More People

Years
  1. 2025 (40)
  2. 2024 (169)
  3. 2023 (263)
  4. 2022 (201)
  5. 2021 (177)
  6. 2020 (208)

More Years

Publications
  1. Blood (840)
  2. Biology of Blood and Marrow Transplantation (516)
  3. Bone Marrow Transplantation (175)
  4. Journal of Clinical Oncology (125)
  5. Transplantation and Cellular Therapy (110)
  6. Blood Advances (88)

More Publications

Publishers
  1. American Society of Hematology (935)
  2. Elsevier Inc. (762)
  3. Nature Publishing Group (258)
  4. American Society of Clinical Oncology (127)
  5. Wiley Blackwell (65)
  6. Taylor & Francis Group (64)

More Publishers

Results (2899)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparison of survival and costs of rituximab-based chemotherapy for initial therapy of follicular lymphoma in elderly patients
    Meeting Abstract

    Shah, G. L.; Winn, A.; Lin, P. J.; Kumar, A. J.; Parsons, S. K.
    Blood (2016)

    Fulltext@MSK | Save
  • A comprehensive analysis of late toxicities and associated risk factors in long-term survivors of myeloablative conditioned allogeneic hematopoietic cell transplantation using ex-vivo CD34+ selection-based graft-versus-host disease prophylaxis
    Meeting Abstract

    Scordo, M.; Shah, G. L.; Kosuri, S.; Herrera, D. A.; Devlin, S.; Maloy, M. A.; Nieves, J.; Borrill, T.; Avecilla, S. T.; Meagher, R. C.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Outcomes of rituximab for EBV viremia/post-transplant lymphoproliferative disease in CD34+ selected allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Poppiti, K.; Lin, A.; Adel, N. G.; Hilden, P.; Castro-Malaspina, H.
    Blood (2016)

    Fulltext@MSK | Save
  • Impact of genomic alterations on outcomes in myelofibrosis patients undergoing allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Rampal, R. K.; Tamari, R.; Zhang, N.; McNamara, C. J.; Rapaport, F.; Litvin, R.; Maloy, M. A.; Castro-Malaspina, H.; Giralt, S.; Weinberg, R. S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A novel intermediate intensity conditioning regimen achieves high rates of long-term outpatient progression-free survival offsetting the disadvantage of early post-transplant complications in adult cord blood (CB) transplant recipients
    Meeting Abstract

    Politikos, I.; Devlin, S.; Yoo, Y.; Mazis, C.; Maloy, M. A.; Scaradavou, A.; Dahi, P. B.; Perales, M.; Giralt, S.; Ponce, D. M.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A Phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M.; Lynch, P.; Scheuerman, M.; Kumar, A.; Gerecitano, J. F.; Zelenetz, A. D.; Hamlin, P. A. Jr; Noy, A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Incidence, severity, day 100 treatment efficacy and therapy toxicity of cytomegalovirus (CMV) infections with early pre-emptive therapy in adult cord blood (CB) transplant recipients
    Meeting Abstract

    Lau, C.; Bhatt, V.; Dahi, P. B.; Devlin, S.; Yoo, Y.; Adel, N. G.; Mazis, C.; Perales, M.; Giralt, S. A.; Koehne, G.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • The VITAL amyloidosis study: A randomized, double-blind, placebo-controlled, global, phase 3 study of NEOD001 in patients with AL amyloidosis and cardiac dysfunction
    Meeting Abstract

    Liedtke, M.; Merlini, G.; Landau, H.; Comenzo, R. L.; Sanchorawala, V.; Weiss, B. M.; Zonder, J. A.; Walling, J.; Kinney, G. G.; Koller, M.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Prognostic factors of CLL patients undergoing reduced intensity allogeneic hematopoietic stem cell transplantation in the immunochemotherapy era
    Meeting Abstract

    Lahoud, O. B.; Hilden, P.; Maloy, M. A.; Dahi, P. B.; Castro-Malaspina, H.; Perales, M. A.; Giralt, S. A.; Sauter, C. S.
    Blood (2016)

    Fulltext@MSK | Save
  • Final results of a phase 2 study of bendamustine in combination with dexamethasone in patients with previously treated systemic light-chain (AL) amyloidosis
    Meeting Abstract

    Lagos, G. G.; Lentzsch, S.; Comenzo, R. L.; Zonder, J.; Osman, K.; Gould, J.; Tsai, W. Y.; Pregja, S.; Reyna, M.; Raza, S.; more...
    Blood (2016)

    Fulltext@MSK | Save